Bozeman, MT — Today, Golden Helix, Inc. announced a multi-year partnership with Sentieon, a company that develops bioinformatics secondary analysis tools to process genomic data. This partnership will integrate Sentieon’s secondary analysis tool with Golden Helix software to provide users with a comprehensive solution for genomic data analysis. Sentieon’s suite of secondary analysis tools made […]
Cambridge, UK – Congenica, a world leader in clinical genomics software for inherited diseases, today announced completion of its recently announced Series B funding round with additional investments from new strategically important investors BGI Genomics (BGI), a recognized global leader in genomics, Healthlink Capital (Healthlink), another well-established China-based life-science investor and Future Planet Capital, a global […]
SANTA CRUZ, Calif. Two Pore Guys, Inc., (2PG) today announced that Jordan Hubbard has joined 2PG as Vice President of Engineering, overseeing both the software and hardware development of the company’s flagship product — a hand-held, single-molecule biosensor using solid-state nanopores. Mr. Hubbard will be responsible for the design and architecture of 2PG’s hardware and […]
CARLSBAD, Calif. — ChromaCode, Inc., a molecular diagnostics company, today announced it has raised $12 million in Series B funding. This latest round is led by New Enterprise Associates (NEA) with participation from existing investors Domain Associates, who led the Company’s Series A round in 2015, and Okapi Ventures. The funding will be used to fuel development […]
One vector targets two genes, creating a combinatorial knockout to speed up the pace of genomic discoveries HUNTSVILLE, Ala. — The simultaneous knockout of two genes can help identify functional relationships between genes, which can lead to a better understanding of biological systems and can have direct implications for cancer therapeutic development as well as other […]
HATFIELD, Pa. — Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to Roche for multiple commercial applications. BD’s patented stochastic labelling technology incorporating molecular indexes (known also as UMIs or molecular barcodes), enables the precise counting of individual biological […]
New SureSeq myPanel™ NGS Custom Cancer Panel content covers a wider range of cancer types with excellent coverage uniformity for confident results. Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq myPanel™ NGS Custom Cancer Panel content. The expansion comes in response to NGS becoming ever more important for research […]
SYDNEY, AUSTRALIA and SOUTH SAN FRANCISCO, CA—SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement with Thermo Fisher Scientific, the world leader in serving science, in support of SpeeDx’s plan to submit its ResistancePlus™ MG Test for clearance by the U.S. Food & Drug Administration (FDA). Under the terms of […]
Oxford Nanopore has launched a new analytical workflow for use with its real time nanopore sequencing devices. ‘ARMA’ allows characterisation of antimicrobial resistance genes in real time. The movie below shows real time analysis of pathogen DNA using two conjoined workflows: ‘What’s in my Pot’ (WIMP) is used for taxonomic classification of pathogens in a sample, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
